Blood markers in advanced thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This study is looking at how certain substances in the blood (called biomarkers) can help doctors understand and treat advanced thyroid cancer. It is for people who are about to start their first systemic therapy (medication that works throughout the body) for advanced thyroid cancer, and who have already had a genetic test on their tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and willing to sign a consent form.
- You have advanced thyroid cancer (well-differentiated, medullary, or anaplastic type) that is ready to start medication that travels through the body.
- A genetic test (multi-gene NGS panel) has already been done on your tumor tissue.
- Your tumors can be seen on standard imaging scans like CT or PET.
- You have not had any prior systemic therapy (medication) for your thyroid cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain blood tests can help predict how head and neck cancer will respond to treatment. If you are planning surgery for squamous cell cancer of the throat, voice box, or mouth, this trial may offer more information about your outlook.
This study looks at a small blood test (called ctDNA) and tumor tissue to understand how advanced thyroid cancers change over time. It may help doctors better monitor cancer growth and guide treatment choices.
This study looks at how different genetic types of advanced thyroid cancer respond to treatment in real-world settings. It may help doctors choose the best therapy for you based on your tumor’s genetic makeup.
This trial tests if an existing drug (used for other conditions) can help people with advanced thyroid cancer who have run out of treatment options. You'll get a new drug and be monitored to see if it shrinks your cancer or slows it down.
This study collects real-world information from patients with advanced thyroid cancer to better understand how standard treatments and specialized procedures work. Your participation will help improve care for others with this type of cancer.
This study uses a simple blood test (ctDNA) to learn more about the genetic makeup of advanced biliary tract cancers. It may help researchers understand how these cancers respond to treatment, and it doesn't involve any extra drugs or procedures—just blood draws.
Hear when a new Thyroid Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.